Inducible high level synthesis of mature human fibroblast interferon in Escherichia coli by Remaut, Erik et al.
Nucleic Acids Research
Inducible high level synthesis of mature human fibroblast interferon in Escherichia coli
Erik Remaut, Patrick Stanssens and Walter Fiers
Laboratory of Molecular Biology, State University of Ghent, Ledeganckstraat 35, 9000 Ghent,
Belgium
Received 7 June 1983; Accepted 27 June 1983
ABSTRACT
We have obtained high level synthesis in Escherichia coli of mature
human fibroblast interferon using a plasmid vector that was designed to
allow easy coupling of a DNA coding region to the initiator AUG of the
replicase gene of the RNA phage MS2 cloned downstream of phage A 's
leftward promoter. The activity of the promoter can be regulated by
temperature. Induced cells accumulated the interferon up to 4% of the
total celjular protein. The biological activity of the product amounted
to 4 x 10 international units per litre of culture. The synthesis of
human fibroblast interferon was shown to drastically inhibit the growth
rate of the bacterial host.
INTRODUCTION
In general, for a given DNA sequence to be expressed into a
polypeptide, the sequence has to be recognized by the host as a
transcriptional and translational unit. In Escherichia coli, the lac
promoter (1,2,3), the trp promoter (4,5) and the leftward promoter PL of
phage A (6,7,8) have been most frequently used to obtain efficient
transcription of downstream gene sequences. Despite an overwhelming body
of sequence data of known ribosome binding sites, our understanding of the
specific factors that determine the efficiency of initiation at a given
ribosome binding site is still very incomplete (for review see ref. 9).
In the absence of clearly defined parameters that, in a predictable way,
govern the rate of expression of a gene, we decided to adapt the
initiating region of a known, well-expressed gene for easy insertion of
any DNA sequence. Our earlier observation that the replicase gene of the
RNA phage MS2, cloned downstream from the PL promoter (10), was expressed
to 35% of de novo protein synthesis as early as 30 min after induction
prompted us to explore the MS2 replicase initiation region as a potential
insertion site for foreign DNA sequences.
We describe the construction and use of a plasmid vector that allows
easy insertion of any coding region downstream of the PL promoter and the
MS2 replicase initiator AUG in phase with the latter. As an example,
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efficient synthesis in E. coli of human mature A -interferon is
demonstrated.
MATERIALS AND METHODS
1. Bacterial strains and Dlasmids
The bacterial strains used in this study are listed in Table I.
Unless otherwise mentioned, the bacteria were grown at 280C in LB medium
(1% Bacto tryptone; 0.5% Bacto yeast extract; 0.5% NaCl).
Plasmids pPLc28, pPLc24 and pPLc2819 were used as the source of DNA
fragments and have been previously described (7,11).
2. DNA methodology
Restriction enzymes were obtained from New England Biolabs, Mass.,
or Boehringer, Mannheim, and used according to the manufacturer's
specifications. T4 DNA ligase was prepared from strain K12AH1Atrp
(pPLc281i9 8) as described (11).
Treatment with Si nuclease (Sigma Chemical Company, St. Louis,) was
performed at 10 C in 200mM NaCl, lmM Zn-acetate, 5OmM Na-acetate,
pH 4.5, for 30 min with a ratio of 5 units of enzyme per 'g DNA.
Protruding 5'-ends were filled in with DNA polymerase I (Klenow fragment)
(Boehringer, Mannheim) at 200C in lOmM MgCl2, 7mM /3-mercaptoethanol, lOmM
Tris-HCl at pH 7.4 in the presence of l001aM of each of the four dNTP's.
Restriction fragments were eluted from agarose gels using the
freeze-squeeze method (12).
Table I List of E. coli strains used
Bacterial strain Genetic characters Source /reference
K12AHlAtrp SmR, lacZam, Abio-uvrB, ref 6
AtrpEA2 (Iam7, Nam53,
c1857,AHI)
M5219 SmR ,lacZam,trpAam, ref 7
GAbio252,cI857,AHl)
K514(A) thr-l,leu-6,thi-1, ref 25
supE44,lacYl ,tonA21,
hsYr',hsm+
MC1061 araDl39,A(ara,leu)7697, ref 26
AlacX74,galU ,galK-,
hsr',hsm strA
SG4044 lac,,lonAl00,A(gal-blu) S. Gottesman
strA
All strains are derivatives of E. coli K-12
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3. Induction of the PL promoter
The expression plasmids used in this study contain the leftward
promoter (PL) of phageA . The plasmids were propagated in a strain
(Kl2AHlAtrp) that supplies a temperature-sensitive repressor, coded for by
a resident defective prophage. The activity of the PL promoter can be
regulated by appropriate choice of the temperature of incubation;
repression is virtually complete at 280C and full induction is obtained at
42 0C. The conditions for induction and detection of induced proteins have
been described (7).
4. Detection of interferon activity in bacterial extracts
Induced cells were harvested by centrifugation and resuspended in 1%
SDS, 1% ,B-mercaptoethanol; 5M urea; 30mM NaCl and 50mM Hepes-buffer
pH 7.0 (13). The cells were lysed by immersion in a boiling water bath
for 3 min. Cell debris was spun down at 12,000 g for 10 min. Serial
dilutions of the lysate were made in Eagle's minimal essential medium
containing 10% foetal calf serum. Interferon activity was measured using
a protection assay of human FS4 cells against cytopathic effect (CPE)
after challenge with EMC virus. CPE was recorded after 24 h. All titres
were calibrated against the NIH human fibroblast interferon reference
G023-902-527.
RESULTS
1. Construction of pPLc245
The initiator ATG codon of the MS2 replicase gene is followed by the
sequence, TCGAA (14). The TaqI site can be converted into a SalI site if
the TCGA sequence were followed by a C residue. To accomplish this a
genuine SalI site was cleaved with TaqI and ligated to the TaqI site
succeeding the ATG codon of the replicase. The details of the
construction are outlined below.
Plasmid pPLc2819 contains the multilinker sequence EcoRI - BamHI -
HindIII - XbaI - PstI - XbaI - SalI - XbaI - HindIII (11). Plasmid
pPLc2819 was cleaved with HaeII and the resulting fragments separated on a
1.4% agarose gel. A 600 bp fragment containing the multilinker sequence
was recovered from the gel. After cleavage with HindIII and TaqI, two
fragments with a HindIII on one end and a TaqI site on the other end were
generated.
Plasmid pPLc24 contains the ribosome binding site and the N-terminal
region of the MS2 replicase gene (7). pPLc24 DNA was digested with Bam HI
and HincII. A 550 bp fragment encompassin'g the MS2 replicase ribosome
binding site was eluted from an agarose gel and further digested with
EcoRI and TaqI. The EcoRI site is located about 130 bp upstream from the
ribosome binding site of the replicase. The TaqI sites are located
immediately after the initiator ATG and at nucleotide 61 within the
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replicase coding region.
Plasmid pPLc28 was cleaved with EcoRI and HindIII and served as the
acceptor for an EcoRI - TaqI fragment and a TaqI - HindIII fragment
obtained from pPLc24 and pPLc2819, respectively. Following ligation, the
mixture was digested with BamHI to counterselect those molecules which had
reconstituted the pPLc28 vector (pPLc28 contains a BamHI site between its
EcoRI site and HindIII site (7)). Transformants were obtained in strain
K514(A ) selecting for resistance to carbenicillin (100 sg/ml).
Among 10 clones analysed, eight had acquired a single SalI site as
predicted by joining the TaqI site in the multilinker sequence of pPLc2819
to the TaqI site succeeding the initiator ATG of the replicase gene. A
representative plasmid, designated pPLc245, was linearized with either
EcoRI or XbaI and produced two fragments after cleavage with PstI (data
not shown). The nucleotide sequence around the ribosome binding site and
initiating ATG of the replicase gene were verified by direct analysis
using the Maxam and Gilbert method (15). pPLc245 DNA was cleaved at its
unique EcoRI site and labelled by filling in of the sticky ends with DNA
polymerase I (Klenow fragment) in the presence of a(32P)ATP. After
restriction with HaeII, the smaller of the labelled fragments was purified
on acrylamide gel and its sequence determined (data not shown). The
sequence of the relevant region of the plasmid is shown in Fig. I.
Sequence at the ATG initiator codon:
AGGATTACCG~I]T lCGCCCTCTAGAGCCTGCAGCCTCTAGAGCCAAGCTT
SD XbaI PstI XbaIHindlI
FIG. 1. Genetic and restriction map of expression plasmid pPLc245. The
amicii~llin resistane gene (ApR), the origin of replication and the P
promoter were derived from pPLc28 (7). Only those restriction sites are
shown which are unique in the plasmid.
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In plasmid pPLc245, the ribosome binding region of the phage MS2
replicase gene is situated downstream from the powerful leftward promoter
(PL) of phageA present on the plasmid. The G-residue of the initiating
ATG codon constitutes the 3'-end of a SailI cleavage site. Thus, the
initiating ATG of the replicase gene can be made accessible to blunt end
ligation after cleavage with SalI and blunting of the 5'-sticky end with
e.g., Si nuclease. In this manner, the coding region of any gene blunted
by appropriate genetic engineering techniques can be joined to the
initiating ATG of the replicase. The 3'-end of the inserted gene can be
either a blunt end, an XbaI, PstI or HindIII site. Other applications
include the sticky ligation of SalI or XhoI fragments into the unique SailI
site. The XbaI sequence following the SailI site of pPLc245 contains a UAG
stop codon in phase with the ATG of the replicase, thus precluding
in-phase insertion at either the XbaI, PstI or HindIII sites. However, by
filling in the SalI site and reclosing the plasmid, the UAG codon can be
moved into another frame. As a consequence, a PvuI site is generated
(this site occurs once more in the /-lactamase gene). Insertion of a
suitable gene fragment in the above mentioned sites could then lead to the
inducible synthesis of a fusion polypeptide with a very short extraneous
N-terminal sequence.
2. Insertion of the human A:-interferon gene into pPLc245
To test the usefulness of pPLc245 for expression of inserted genes, we
cloned the sequence coding for mature human A-interferon (HFIF) (13)
downstream from the initiating ATG of pPLc245.
Plasmid pPLc245 was digested with SalI and treated with S, nuclease.
The DNA was further digested with HindIII and loaded on a 1.2% agarose
gel. A band corresponding to linear pPLc245 was eluted from the gel. As
a source of the coding region for mature human k-interferon, we used a
recombinant DNA molecule into which an XbaI site had been engineered in
front of the sequence coding for mature /-interferon (details of the
construction of this plasmid (pPLcRXl9) are described in ref. 16). In
plasmid pPLcRXl9, the sequence at the ATG codon of mature interferon (13)
reads -TCTAGATG-. Following XbaI cleavage and S, nuclease treatment, the
ATG codon of mature k-interferon can be made accessible as a 5'blunt
end. In plasmid pPLcRXl9, the coding sequence of k-interferon is
followed by a HindIII site. Hence, plasmid pPLcRXl9 was digested with
XbaI, treated with Si nuclease and further digested with HindIII. A 520
bp fragment encompassing the complete coding region for /-interferon was
eluted from the gel and ligated to the above mentioned SalI-, Sl- and
HindIII-treated sample of pPLc245. Transformants were obtained in strain
K12AHlAtrp selecting for resistance to carbenicillin (100 jug/ml). To
search for an in phase junction of the coding region for mature
A-interferon to the ATG codon of the MS2 replicase, we made use of the
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observation that even marginal expression of k-interferon led to a
drastic reduction of the growth rate of the bacteria (see below). Using
this simple screening method, we found one transformant among 32 tested
which grew normally at 280C but virtually failed to grow at 420C. This
clone harbored a plasmid which had lost the SalI site present in the
acceptor plasmid pPLc245. The plasmid contained two PstI sites consistent
with the insertion of the k-interferon gene into the vector pPLc245. One
PstI site is present in the ApR-gene of pPLc245 and another is present in
the coding region of k-interferon (13). The plasmid contained a single
EcoRI and a single HindIII site. Combined digestion with EcoRI and
HindIII produced a fragment slightly larger than an XbaI - HindIII
fragment obtained from pPLcRXl9 (see above), again consistent with the
insertion of the k-interferon gene in pPLc245. This plasmid was
designated pPLc245-HFIF25.
In order to verify the structure of pPLc245-HFIF25, plaiTid DNA was
cleaved with EcoRI, filled in at the staggered ends with a P-ATP and
digested with PvuII (a unique site present in the k-interferon coding
region (13)). The smaller of the two labelled fragments was purified on a
6% acrylamide gel and subjected to sequence analysis according to Maxam
and Gilbert (15). The sequence around the junction point between the
blunted SalI site of pPLc245 and blunted XbaI site of pPLcRXl9 reads:
TGAGGATTACCCATGAGCTAC (data not shown). The construction scheme of
pPLc245-HFIF25 predicted the presence of two ATG codons at the junction
point; one derived from the initiator region of pPLc245 and one derived
from the mature t-interferon sequence. The results show that one ATG
codon was lost either from the blunted SalI site of pPLc245 or the blunted
XbaI site of pPLcRXl9, presumably due to overdigestion by the S1 nuclease.
3. Synthesis of mature : -interferon
The synthesis of mature k-interferon in induced cultures of strain
K12AHlAtrp (pPLc245-HFIF25) was monitored by the appearance of a new
protein and by detection of k-interferon activity in bacterial extracts.
The cells were grown in LB medium at 28 C to a density of 2 x 10 /ml. An
aliquot of the culture was then shifted to 420C and samples were analysed
on SDS-polyacrylamide gels. In the induced cells, a new major protein
with an apparent molecular weight of around 19K was detected (Fig. 2).
This protein was absent in induced cultures of the parent plasmid
pPLc245. The observed molecular weight is consistent with the molecular
weight of mature k-interferon calculated from sequence data (13).
In order to determine the amount of k-interferon synthesized, the
cellular proteins were uniformly labelled. The cells ere inoculated at a
density of 10 /ml in LB medium containing 5 uCi/ml of C-amino acid
mixture (The Radiochemical Centre, Amersham, England) and grown at 28 C to
a density of 2 x 10 /ml. Following an induction period of 180 min at
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KtFig 2.Bacterial synthesis of fibroblast interferon.
Cultures of strain K12ilHlAtrp containing either pPLc245 or
pPLc245-HFIF25 were grown and thermo-induced as described in the text. At
90 min and 180 min after induction, aliquots were collected, boiled in SDS
and electrophoresed in a 12.5% polyacrylamide gel. The gel was stained
with Serva blue R250. Each lane contains the equivalent of 1 x 108 cells.
The interferon band is shown by a triangle. As molecular weight
standards, we used a set of methylated 14C-labelled proteins (New England
Nuclear, Boston, Mass.).
420C, the cellular proteins were separated on SDS-polyacrylamide gels and
the radioactivity incorporated in individual protein bands was
determined. Under the conditions used, it can be assumed that the
incorporated radioactivity reflects the actual amount of protein present
in the cell. The induced 19K protein was found to account for 2% of
total cell protein. This corresponds to about 100,000 molecules per cell.
The biological activity of the bacterially made interferon was assayed
as described in Materials and Methods. Using this procedure, we found
that strain K12AHlAtrp (pPLc245-HFIF25), induced for 180 min, produced an
interferon titre of between 2-6 x 10 international units per litre of
culture at a cell density of 4 x 108/ml. Uninduced cultures contained
less than 3 x l0 units per litre (this value represents the limit of
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Fig. 3. Effect of fibroblast interferon synthesis on the growth rate of
E. col.
detection in the assay system used; due to the presence of SDS, the first
serial dilutions of the bacterial extracts are toxic to the FS4 cells).
4. Influence of interferon synthesis on host cell metabolism
Figure 3 shows the growth rate of the E. coli strain K12AHlAtrp
synthesizing either human A -interferon or phage T4 DNA ligase (11).
Remarkably, the synthesis of interferon which is quantitatively less than
that of ligase (2% versus 10% of total cellular protein) drastically
reduces the growth rate of the bacteria. The effect was observed in
several bacterial strains. In order to study interferon synthesis
directed by pPLc245-HFIF25 in E. coli strains which do not harbor a
defective A prophage, these strains were first transformed with pcI857.
This plasmid is compatible with ColEl-derived replicons and codes for a
temperature sensitive repressor (11). We found that the amount of
a-interferon accumulating in the cells after induction differed greatly,
depending on the strain tested. The results are summarized in Table II.
Although, e.g., strain MC1061 (pcI857) (pPLc245-HFIF25) accumulates
interferon to only one fifth of the value found for strain K12AHlAtrp, its
growth rate is still severely inhibited after induction. It should be
noted that we have not measured actual rates of synthesis but merely
accumulation of the product after a 3 h induction period. It is possible
that the synthesis rate does not differ greatly, but rather that the
interferon is degraded differentially in the several strains. In favor of
this hypothesis is the observation that a deg strain (17), which is
impaired in its proteolytic degradation system, allows accumulation of the
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Table II Synthesis of 0-interferon in different
strains containing pPLc245-HFIF25
IFN-activity(b)
Strain % of total protein(a) units/L culture
K12AHlAtrp 2% 2 x 10
M5219 ND 2 x 107
MC1061 (pcI857) 0.4% 4 x 108
SG4044 (pcI857) 4% ND
a) the total amount of protein synthesized was determined as described in
the text; b) the cell density of the cultures at the time of induction was
4 x 108 /ml; the induction period was 3 h; ND = not determined
product up to 4% of total cell protein. The latter strain is particularly
well suited for large scale production of interferon. Unlike strain
K12AHlAtro, which for an unknown reason cannot be grown to very high
densities, strain SG4044 can do so in rich media and under conditions of
forced aeration.
The very low interferon titres found in strain M5219 are unlikely to
be due solely to increased proteolytic breakdown, since the strain is
isogenic with K12AHlAtrp. Upon induction, strain M5219 synthesizes an
active N-gene product from the defective prophage. The N-protein in
conjunction with a nut site is known to function as an antiterminator for
transcription initiated at PL or PR (18). We have previously shown that
prolonged induction of pPLc plasmids in M5219 leads to curing of the
plasmid (7). However, analysis of plasmid DNA of induced cells shows that
the curing is not rapid enough to account for the much lower interferon
titre in this strain (data not shown). It is possible that a long
untranslated 3'-end of the message renders it more susceptible to
nucleolytic breakdown or, through structural effects, less efficient for
initiation of translation.
DISCUSSION
We have previously described the use of the PL promoter of phage A
cloned on plasmids, for efficient transcription of downstream gene
sequences. The system allows full control over the expression of the gene
by making use of a temperature-sensitive repressor, product of the cI857
gene supplied in trans from a resident defective prophage or from a
compatible plasmid (6,7,11). However, these vectors did not contain an
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easily accessible ribosome binding site. The expression of an inserted
gene depended, therefore, on the presence and the functionality in E. coli
of its own ribosome binding site.
In this paper we describe the incorporation into PL-vectors of a
ribosome binding site in such a way that the ATG codon can easily be made
accessible for insertion of any coding sequence. For this purpose, we
decided to use the ribosome binding-site and ATG codon of the replicase
gene of the RNA phage MS2. The rationale for this choice was based on the
observation that the MS2 replicase cloned downstream from the PL promoter
was induced to very high levels in the cell (10). Similarly, a fusion
polypeptide between an amino-terminal fragment of MS2 replicase and the
VPl protein of Foot and Mouth Disease Virus was produced in large amounts
in E. coli (19). To expose the initiating ATG codon of the replicase, we
transformed a TaqI site right after the ATG into a unique SalI site.
After cleavage with SalI and resection of the 5' protruding end with,
e.g., Si nuclease, the ATG-codon is accessible as a blunted end. In
plasmid pPLc245, the SalI site is followed by the sequence: XbaI - PstI -
XbaI - HindIII. Except for the PstI site which occurs once more in the Ap
gene, these sites are unique in the plasmid. Any coding region blunted at
the 5'-end can thus be inserted in phase with the initiating ATG of the
replicase; the 3'-end of the inserted fragment can be a blunt end or an
XbaI, PstI or HindIII end.
To test the effectiveness of pPLc245, we inserted the coding region
for mature human fibroblast $-interferon downstream from the ATG of MS2
replicase. Induced cultures containing pPLc245-HFIF25 accumulated the
protein to about 2%-4% of total cellular protein depending on the lost
strain, as determined by measuring actual protein content. The induced
protein was easily detected by staining of cellular proteins
electrophoresed in polyacrylamide gels. The product was biologically
active as determined by a cytopathic effect-inhibition assay. Titres of
2-6 x 109 international units per litre of culture at a cell density of
4 x 108/ml were obtained. This value is considerably higher than the
titres reported previously for human a -interferon expressed under the
control of the E. coli lac promoter (20,21) or the E. coli trp promoter
7 ~~~~~~~~~~~~~~8(21,22). Assuming a specific biological activity of 4 x 10 IU/mg (23),
we calculated the interferon to be present at about 400,000 molecules per
cell. From the determination of actual protein content we found a value
of about 100,000 molecules per cell. These two values are in reasonable
agreement with each other. The comparison shows that our method of
extraction is not harmful to the protein.
The amount of biologically detectable interferon in uninduced cells
was at least five orders of magnitude lower than the amount found after a
three hour induction period. It is unclear whether this difference is
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caused by the sole action of repressor. Indeed, uninduced basal levels of
trpA gene cloned on PL-plasmids were only three-hundred fold lower than
the induced level (7). One possibility is that the small amount of
protein which is produced at 280C is much more liable to be degraded by
the host's proteases. Stabilization of intrinsically unstable proteins by
overproduction in E. coli has been noted, e.g., in the case of a nonsense
fragment of j-galastosidase (24).
Remarkably, bacterial cultures containing pPLc245-HFIF25 almost ceased
to grow after shift-up to 420C. This is a rather specific effect, neither
observed with the vector itself, nor with a similar vector synthesizing
large amounts of plasmid-coded T4 DNA ligase (11). We do not know whether
the effect is a direct or indirect consequence of the synthesis of
interferon, nor have we studied at what level the synthesis of interferon
interferes with bacterial metabolism. Possibly, it may be related to the
fairly hydrophobic nature of j-interferon which causes the protein to
stick to the bacterial membrane. In any case, this observation stresses
the importance of being able to regulate the expression of a cloned gene.
We observe that a bacterial strain containing pPLc245-HFIF25 grows quite
normally at 28 C under non-expressing conditions, but is severely impaired
in its growth rate at 420C when the inserted gene is maximally expressed.
As a consequence, it would appear that a host-vector system which does not
allow full control over the expression of an inserted gene will tend to be
unstable and will have a negative selection value. In pPLc245, the
expression of an inserted gene can be completely repressed by propagating
the culture at 28 C. Full scale production of a gene product is
subsequently obtained at 42 C in a terminal phase of the culture.
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